Search Results 1681-1690 of 19429 for hemoglobin

  1. Neurology - Clinical trials

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  2. Neurology - Clinical trials - Mayo Clinic

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  3. Neurology - Clinical trials - Mayo Clinic

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  4. A Drug-drug Interaction Study of Avapritinib and Midazolam to Treat Unresectable or Metastatic Gastrointestinal Stromal Tumors and Other Advanced Solid Tumors - Mayo Clinic

    Hemoglobin < 9 g/dL. Transfusion and erythropoietin may be used to reach at least 9 g/dL but must have been administered at least 2 weeks before the first ...

  5. Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell Lymphoma - Mayo Clinic

    Hemoglobin ≥ 7.5 g/dL (4.7 mmol/L);; Serum aspartate transaminase (AST/SGOT) and alanine transaminase (ALT/SGPT) ≤ 3.0 x upper limit of normal (ULN). In ...

  6. A Study to Evaluate the Effectiveness, Safety and Way in Which the Body Processes REGN3500 in Adults with Moderate-to-Severe Atopic Dermatitis - Mayo Clinic

    Examples include, but are not limited to, patients with short life expectancy, patients with uncontrolled diabetes (hemoglobin A1c [HbA1c] ≥9%), patients ...

  7. A Phase I, Multi-Center, Open Label, Dose De-escalation and Expansion Study of Gemcitabine and Cisplatin with AG120 or Pemigatinib for Advanced Cholangiocarcinoma - Mayo Clinic

    Hemoglobin ≥ 8 g/dL (obtained ≤ 21 days prior to registration). Serum total bilirubin ≤ 2.0 x upper limit of normal (ULN), unless considered due to ...

  8. A Study to Assess the Effectiveness and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis - Mayo Clinic

    Examples include, but are not limited to, patients with short life expectancy, patients with uncontrolled diabetes (hemoglobin A1c ≥ 9%), patients with ...

  9. A Study to Evaluate TVB-2640 and Trastuzumab Plus Paclitaxel or Endocrine Therapy for Treating Patients with HER2 Positive Advanced Breast Cancer - Mayo Clinic

    Hemoglobin ≥ 9.0 g/dL;; Absolute neutrophil count (ANC) ≥ 1500/mm^3; Platelet count; ≥ 100,000/mm^3;; Direct bilirubin ≤ 1.5 x ULN;; Aspartate transaminase ...

  10. A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment - Mayo Clinic

    Hemoglobin < 8 g/dL;; Platelets < 100,000/μL;; Positive serum pregnancy test at the Screening visit or positive urine pregnancy test at the Baseline visit ...